2788
HETEROCYCLES, Vol. 75, No. 11, 2008
2H, J = 12 Hz, Isoquinoline-CH2), 3.47 (t, 2H, J = 12 Hz, Isoquinoline-CH2), 4.09 (m, 4H,
Isoquinoline-2CH2O), 6.68 (s,1H, Isoquinoline-CH), 7.0 (s,1H, Isoquinoline-CH), 7.22-7.25 (d, 2H, J =
7.8 Hz, Ar H), 7.48-7.58 (m, Ar H), 7.66-7.69 (d, 2H, J = 7.8 Hz, Ar H), 7.87 (s,1H, Ar H). 13C NMR (75
MHz, DMSO-d6): δ 14.54, 14.65, 20.80, 27.85, 42.09, 63.90, 64.07, 108.24, 111.21, 112.43, 113.14,
117.49, 118.03, 121.53, 123.88, 125.90, 127.93, 128.66, 129.44, 130.36, 133.97, 137.53, 145.97, 149.54,
150.81, 151.74. Anal. Calcd for C30H28N4O2: C, 75.61; H, 5.92; N, 11.76. Found: C, 75.49; H, 5.93; N,
11.58 %.
2,3,5,6-Tetrahydro-8,9-diethoxy-3-(p-tolyl)-[1,2,3]triazolo[5,1-a]isoquinoline-1-carbonitrile 16
To a cold solution of the appropriate isoquinolinium bromide salts 11a,b,d (2 mmol) in base-free absolute
o
EtOH (20 mL), p-tolyldiazonium salt (2 mmol) was added portionwise over 1 h at 0-5 C. After the
addition was completed, the reaction mixture was left to stir at rt overnight then diluted with 10 mL water.
The precipitate so formed was filtered off, washed with MeOH and dried. Recrystallization from EtOH
afforded the corresponding 1,2,3-triazolo[5,1-a]isoquinoline-1-carbonitrile 16 Yield (65%); mp 193-195
1
oC (DMF-EtOH); IR (KBr) υ 3380 (NH), 2205 (C≡N) cm-1; H NMR (DMSO-d6): δ 1.38 (m, 6H,
Isoquinoline-2CH3), 2.17 (s, 3H, CH3), 2.34 (t, 2H, J = 6.9 Hz, Isoquinoline-CH2), 3.52 (t, 2H, J = 6.9 Hz,
Isoquinoline-CH2), 4.10 (m, 4H, Isoquinoline-2CH2O), 5.13 (s, 1H, Triazole-NH), 6.66 (s, 1H,
Isoquinoline-CH), 6.90 (s, 1H, Isoquinoline-CH), 7.25 (d, 1H, J = 8.7 Hz, Ar H), 7.47-7.65 (m, 1H, Ar H),
7.86 (s, 1H, Ar H), 8.0 (d, 1H, J = 8.7 Hz, Ar H); 13C NMR (75 MHz, DMSO-d6): δ 14.52, 14.61, 20.79,
27.81, 42.09, 45.33, 64.07, 112.48, 113.20, 117.48, 120.68, 121.57, 128.66, 129.41, 133.26, 137.50,
145.95, 151.73; MS m/z (%) 376 (M+, 78), 301 (37.4), 258 (19.9), 91 (78). Anal. Calcd for C22H24N4O2: C,
70.19; H, 6.43; N, 14.88. Found: C, 70.34; H, 6.29; N, 14.69 %.
REFERENCES
1. (a) H. Dong, C. M Lee, W. L. Huang, and S. X. Peng, Br. J. Pharmacol., 1992, 107, 262. (b) H.
Dong, J. Z. Sheng, C. M. Lee, and T. M. Wong, Br. J. Pharmacol., 1993, 109, 113. (c) V. S. Bernan,
D. A. Montenegro, J. D. Korshalla, W. M. Maiese, D. A. Steinberg, and M.Greenstein, J. Antibiot.,
1994, 47, 1417. (d) S. Urverg-Ratsimamanga, P. Rasoanaivo, H. Rafatro, B. Robijaona, and A.
Rakato-Ratsimamanga, Ann. Trop. Med. Parasitol., 1994, 88, 271. (e) M. D. Rozwadowska,
Heterocycles, 1994, 39, 903.
2. (a) K. Iwasa, M. Moriyasu, Y. Tachibana, H.-S. Kim, Y. Wataya, W. Wiegrebe, K. F. Bastow, L. M.
Cosentino, M. Kozuka, and K.-H. Lee, Bioorg. Med. Chem., 2001, 9, 2871. (b) J. D. Scott and R. M.
Williams, Chem. Rev., 2002, 102, 1669. (c) K. W. Bentley, Nat. Prod. Rep., 2002, 19, 332. (d) A. B.
J. Bracca and T. S. Kaufman, Tetrahedron, 2004, 60, 10575.